Medical therapy for asymptomatic men with benign prostatic hyperplasia: primum non nocere.
Kaplan
Steven A
SA
D058891:5-alpha Reductase Inhibitors; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003362:Cost-Benefit Analysis; D018450:Disease Progression; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D015995:Prevalence; D011470:Prostatic Hyperplasia / Q000150:complications / Q000188:drug therapy* / Q000191:economics; D019564:Unnecessary Procedures; D014555:Urination Disorders / Q000209:etiology
D058891:5-alpha Reductase Inhibitors; D004791:Enzyme Inhibitors